Reducing the impact of white matter lesions on automated measures of brain gray and white matter volumes.
about
Clinical use of brain volumetry.Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosisThe role of MRI in the evaluation of secondary progressive multiple sclerosis.Structural MRI correlates of cognitive impairment in patients with multiple sclerosis: A Multicenter Study.Brain reserve and cognitive reserve protect against cognitive decline over 4.5 years in MS.White matter hyperintensities are seen only in GRN mutation carriers in the GENFI cohort.The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis.Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration.Memory in multiple sclerosis is linked to glutamate concentration in grey matter regionsWhite matter lesion filling improves the accuracy of cortical thickness measurements in multiple sclerosis patients: a longitudinal studyRegional patterns of grey matter atrophy and magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups: a voxel-based analysis study.Quantification of global cerebral atrophy in multiple sclerosis from 3T MRI using SPM: the role of misclassification errors.Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis MethodSearching for the neural basis of reserve against memory decline: intellectual enrichment linked to larger hippocampal volume in multiple sclerosis.The impact of lesion in-painting and registration methods on voxel-based morphometry in detecting regional cerebral gray matter atrophy in multiple sclerosisEvidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosisReduced gamma-aminobutyric acid concentration is associated with physical disability in progressive multiple sclerosis.Non-Local Means Inpainting of MS Lesions in Longitudinal Image ProcessingMulti-channel registration of fractional anisotropy and T1-weighted images in the presence of atrophy: application to multiple sclerosis.Serial proton MR spectroscopy of gray and white matter in relapsing-remitting MSThe effect of daclizumab on brain atrophy in relapsing-remitting multiple sclerosis.Quantifying brain volumes for Multiple Sclerosis patients follow-up in clinical practice - comparison of 1.5 and 3 Tesla magnetic resonance imaging.Effect of in-painting on cortical thickness measurements in multiple sclerosis: A large cohort study.DIR-visible grey matter lesions and atrophy in multiple sclerosis: partners in crime?Patterns of white matter damage are non-random and associated with cognitive function in secondary progressive multiple sclerosis.A multi-time-point modality-agnostic patch-based method for lesion filling in multiple sclerosisA comprehensive approach to the segmentation of multichannel three-dimensional MR brain images in multiple sclerosis.Dynamic imaging of individual remyelination profiles in multiple sclerosis.Accurate white matter lesion segmentation by k nearest neighbor classification with tissue type priors (kNN-TTPs).Analysis of ageing-associated grey matter volume in patients with multiple sclerosis shows excess atrophy in subcortical regions.Accurate GM atrophy quantification in MS using lesion-filling with co-registered 2D lesion masksNeuroprotective effects of testosterone treatment in men with multiple sclerosis.Advances in imaging to support the development of novel therapies for multiple sclerosis.Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage.Agreement of MSmetrix with established methods for measuring cross-sectional and longitudinal brain atrophy.Dysregulation of energy metabolism in multiple sclerosis measured in vivo with diffusion-weighted spectroscopy.The effects of white matter disease on the accuracy of automated segmentation.Reliable measurements of brain atrophy in individual patients with multiple sclerosis.Reduced grey matter perfusion without volume loss in early relapsing-remitting multiple sclerosis.Elevated CSF neurofilament proteins predict brain atrophy: A 15-year follow-up study.
P2860
Q30582479-EC5200AE-792B-49ED-BFC1-3729B0F91654Q30582882-92D65CD0-5FDF-4142-9058-929DB356EB63Q31033345-042CBB3B-6800-4B78-A0CA-5F04DF9C6DA3Q31042055-D2B23CC6-E926-4952-AC10-0264C9CD13FAQ33672609-68EAEF56-052E-4B46-A85E-56D64C22FB33Q33676267-00488D87-DD0A-4AC3-BC5A-E719B4095D5AQ33698702-81C0DD1D-0D68-4932-BB96-2ECBE73AF900Q33937672-0506EDE5-C4C5-4BF4-88FB-FB1157BA479AQ33956723-73ED4D09-C9B9-46A2-A8F3-D7E4E57D92ECQ34184999-F16A53DB-E9B3-46FE-9EA7-63E6D9D9691DQ35329447-EE87C6D9-A015-4B5E-9A68-C50A2546B37EQ35535764-B69A5262-F86E-4AC3-B26C-E17A5044BDD9Q35888929-CD9074BD-89D0-478B-A585-3CF25A46D494Q35915811-78FB3A92-9513-4143-B71A-838BFCB05B72Q36183159-119A8E85-6AF8-4FB6-A43A-113B41476343Q36186773-507F97BE-E00A-4E03-9310-FDCB128F60EDQ36276516-789D0EF3-533F-4AD8-AB28-AB44F1D96D94Q36369426-1672EA14-A427-4923-A6BB-25CC03FF099BQ36593617-399CEAFC-F128-4695-A1AB-B948FF9AE0B1Q36659440-99A3661B-9CA3-4649-BB31-56CEEC3CB650Q36748094-ABA5518D-B403-4DDA-921D-D247E201E83CQ36807642-B421A49D-4F69-4F47-9575-F16E3D31BE3CQ36820970-C1E033E5-33FF-4D78-97D9-AD2F1B8AE350Q36859508-8ABE5E8A-2B4F-42A1-BC78-21D3C22B268BQ37064183-7A7A9BFE-9BA2-41D3-9B68-9EA7A0982442Q37184014-682D7402-5931-49E9-97B1-0F68A2FFD80FQ37184546-9C6ED3BD-F42D-43C6-BDF0-BC3102FE6B37Q37221998-0F3023A1-0226-4CC0-A31E-4E2C613811FDQ37313961-30695023-61F8-4253-892C-7515B772E877Q37433538-B46B3D86-8F88-4E58-843B-4C99EDAF0648Q37594769-E024D7E7-4FA3-4DCF-909B-924F1B6CFA3CQ37634705-845677B7-688F-45FB-A1C9-8A4401882B2AQ37991519-D430ED17-4013-4C3A-ACD8-720B83A976EEQ38444650-2BB5BB75-FC3C-46F0-BC69-5A73B141CD96Q38631344-9DFBDA4A-3F0E-4A2D-800B-A540DAC6AB2AQ38732541-93567969-2B85-4B70-8687-1E6297948DA9Q38859197-E8C5C1BB-752C-4071-A062-1182C3FD1B90Q39335452-EF0409D6-6AEF-4486-AE40-7F869737D363Q39349758-A6222E47-7D97-4E4B-B958-95A959AB69C8Q39748242-32727395-C0A2-4CB3-985A-94075B2C55F3
P2860
Reducing the impact of white matter lesions on automated measures of brain gray and white matter volumes.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Reducing the impact of white m ...... gray and white matter volumes.
@en
Reducing the impact of white m ...... gray and white matter volumes.
@nl
type
label
Reducing the impact of white m ...... gray and white matter volumes.
@en
Reducing the impact of white m ...... gray and white matter volumes.
@nl
prefLabel
Reducing the impact of white m ...... gray and white matter volumes.
@en
Reducing the impact of white m ...... gray and white matter volumes.
@nl
P356
P1476
Reducing the impact of white m ...... gray and white matter volumes
@en
P2093
David H Miller
Jonathan S Jackson
P2860
P304
P356
10.1002/JMRI.22214
P577
2010-07-01T00:00:00Z